Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients

NCT: NCT06793735 · RECRUITING

NCT IDNCT06793735
StatusRECRUITING
Start Date2025-01-08
Completion2026-12-31

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of a telerehabilitation program combined with a virtual reality (VR) app in improving cognitive performance and social skills in patients with Subjective Cognitive Decline (SCD) and Mild Cognitive Impairment (MCI). The main questions it aims to answer are: Can a VR telerehabilitation program improve cognitive functions and social skills in patients with SCD and MCI? Are there measurable changes in brain activity, eye movements, and gait patterns after the intervention? Researchers will compare telerehabilitation with a VR group (Experimental Group - EG) to a traditional paper-based cognitive rehabilitation group (Active Control Group - aCG) to determine which approach is more effective. Participants will: Undergo an initial assessment, including neurological exams, neuropsychological tests, brain MRI, EEG, eye movement analysis, and gait evaluation. Participate in a 6-week intervention program: EG: Use VR apps on smartphones/tablets at home, guided remotely by a therapist. aCG: Perform traditional cognitive exercises using paper-based tasks. Complete follow-up assessments immediately after the intervention and again after three months. This study will help determine whether telerehabilitation with VR can provide measurable cognitive and social benefits, contributing to improved care strategies for individuals at risk of dementia.

Frequently Asked Questions

What is Effectiveness of TeleVR App in Cognitive Decline and MCI Patients?

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients is a clinical trial registered under NCT06793735. Current status: RECRUITING.

What is the status of NCT06793735?

The current status of NCT06793735 (Effectiveness of TeleVR App in Cognitive Decline and MCI Patients) is: RECRUITING.

When did Effectiveness of TeleVR App in Cognitive Decline and MCI Patients start?

Effectiveness of TeleVR App in Cognitive Decline and MCI Patients started on 2025-01-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.